AR054790A1 - Metodos para el tratamiento de disfuncion sexual - Google Patents
Metodos para el tratamiento de disfuncion sexualInfo
- Publication number
- AR054790A1 AR054790A1 ARP060102653A ARP060102653A AR054790A1 AR 054790 A1 AR054790 A1 AR 054790A1 AR P060102653 A ARP060102653 A AR P060102653A AR P060102653 A ARP060102653 A AR P060102653A AR 054790 A1 AR054790 A1 AR 054790A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogen
- group
- compound
- treatment
- sexual dysfunction
- Prior art date
Links
- 201000001880 Sexual dysfunction Diseases 0.000 title abstract 2
- 231100000872 sexual dysfunction Toxicity 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 150000001923 cyclic compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- -1 nitro, hydroxy Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000005309 thioalkoxy group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Método para el tratamiento de la disfuncion sexual en un sujeto, que comprende la etapa de la administracion de una cantidad terapéuticamente eficaz de un compuesto de la formula (1), o una sal aceptable para uso farmacéutico de dicho compuesto, o su éster; donde: Rx es un miembro seleccionado del grupo que consiste en hidrogeno, alquilo inferior C1-8, halogeno seleccionado de F, Cl, Br e I, alcoxi C1-3, nitro, hidroxi, trifluormetilo y tioalcoxi C1-3; x es un entero de 1 a 3, con la condicion de que R puede ser igual o diferente cuando x es 2 o 3; R1 y R2 pueden ser iguales o diferentes entre sí, y se seleccionan de manera independiente del grupo que consiste en hidrogeno, alquilo inferior C1-8, arilo, arilalquilo, cicloalquilo C3-7; R1 y R2 pueden unirse para formar un heterociclo de 5 a 7 miembros sustituido con un miembro seleccionado del grupo que consiste en hidrogeno, grupos alquilo y arilo; donde el compuesto cíclico puede comprender 1 a 2 átomos de nitrogeno y 0 a 1 átomo de oxígeno; donde los átomos de nitrogeno no están conectados directamente entre sí o con el átomo de oxígeno.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69280905P | 2005-06-22 | 2005-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054790A1 true AR054790A1 (es) | 2007-07-18 |
Family
ID=37067408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060102653A AR054790A1 (es) | 2005-06-22 | 2006-06-21 | Metodos para el tratamiento de disfuncion sexual |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8552060B2 (es) |
| EP (1) | EP1893291B1 (es) |
| JP (1) | JP5298334B2 (es) |
| KR (1) | KR101335942B1 (es) |
| AR (1) | AR054790A1 (es) |
| AT (1) | ATE459393T1 (es) |
| CA (1) | CA2612672C (es) |
| DE (1) | DE602006012670D1 (es) |
| ES (1) | ES2344469T3 (es) |
| MY (1) | MY145066A (es) |
| TW (1) | TWI387452B (es) |
| WO (1) | WO2007001841A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1890684T3 (pl) | 2005-06-08 | 2014-05-30 | Sk Biopharmaceuticals Co Ltd | Leczenie zaburzeń snu i czuwania |
| AU2010270971B2 (en) | 2009-06-22 | 2015-08-20 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating or preventing fatigue |
| CA2779442A1 (en) | 2009-11-06 | 2011-05-12 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
| ES2447295T3 (es) * | 2009-11-06 | 2014-03-11 | Sk Biopharmaceuticals Co., Ltd. | Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| SG11201507121RA (en) | 2013-03-13 | 2015-10-29 | Aerial Biopharma Llc | Treatment of cataplexy |
| JP6529495B2 (ja) | 2013-07-18 | 2019-06-12 | ジャズ ファーマスティカルズ インターナショナル スリー リミテッドＪａｚｚ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｉｉ Ｌｉｍｉｔｅｄ | 肥満の治療 |
| TWI698415B (zh) | 2014-02-28 | 2020-07-11 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
| US10888542B2 (en) | 2014-02-28 | 2021-01-12 | Sk Biopharmaceuticals Co., Ltd. | Aminocarbonylcarbamate compounds |
| JP6466792B2 (ja) * | 2015-07-03 | 2019-02-06 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 注意欠陥／多動性障害（ａｄｈｄ）の治療方法 |
| CN109996540A (zh) * | 2016-09-06 | 2019-07-09 | 爵士制药国际Iii有限公司 | (r)-2-氨基-3-苯丙基氨基甲酸酯的溶剂化物形式 |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| EP4316592A3 (en) | 2016-10-06 | 2024-05-01 | Axsome Malta Ltd. | Carbamoyl phenylalaninol compounds and uses thereof |
| KR20200016889A (ko) | 2017-06-02 | 2020-02-17 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 과다 졸림증을 치료하기 위한 방법 및 조성물 |
| CA3071779A1 (en) | 2017-07-31 | 2019-02-07 | Jazz Pharmaceuticals Ireland Limited | Carbamoyl phenylalaninol analogs and uses thereof |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
| WO2025006965A1 (en) | 2023-06-29 | 2025-01-02 | Axsome Therapeutics, Inc. | Methods of administering solriamfetol to lactating women |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ260667A (en) * | 1993-06-10 | 1997-05-26 | Lilly Co Eli | Preventing emesis or treating sexual dysfunction using tetrahydrobenz[cd]indole 6-carboxamides |
| KR100197892B1 (ko) | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
| KR0173862B1 (ko) | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| US6228864B1 (en) * | 1997-10-28 | 2001-05-08 | Vivus, Inc. | Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation |
| US20050203130A1 (en) | 2003-12-02 | 2005-09-15 | Erik Buntinx | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| JP2008518921A (ja) * | 2004-10-28 | 2008-06-05 | エスケー ホルディングス カンパニー リミテッド | うつ病のための補助療法 |
| PL1890684T3 (pl) | 2005-06-08 | 2014-05-30 | Sk Biopharmaceuticals Co Ltd | Leczenie zaburzeń snu i czuwania |
-
2006
- 2006-06-13 KR KR1020087001754A patent/KR101335942B1/ko active IP Right Grant
- 2006-06-13 EP EP06773098A patent/EP1893291B1/en active Active
- 2006-06-13 JP JP2008518221A patent/JP5298334B2/ja active Active
- 2006-06-13 ES ES06773098T patent/ES2344469T3/es active Active
- 2006-06-13 US US11/922,128 patent/US8552060B2/en active Active
- 2006-06-13 WO PCT/US2006/023068 patent/WO2007001841A1/en active Application Filing
- 2006-06-13 DE DE602006012670T patent/DE602006012670D1/de active Active
- 2006-06-13 CA CA2612672A patent/CA2612672C/en not_active Expired - Fee Related
- 2006-06-13 AT AT06773098T patent/ATE459393T1/de not_active IP Right Cessation
- 2006-06-20 MY MYPI20062920A patent/MY145066A/en unknown
- 2006-06-21 AR ARP060102653A patent/AR054790A1/es unknown
- 2006-06-21 TW TW095122189A patent/TWI387452B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080028445A (ko) | 2008-03-31 |
| CA2612672A1 (en) | 2007-01-04 |
| CA2612672C (en) | 2014-10-14 |
| ATE459393T1 (de) | 2010-03-15 |
| ES2344469T3 (es) | 2010-08-27 |
| US20090221553A1 (en) | 2009-09-03 |
| US8552060B2 (en) | 2013-10-08 |
| WO2007001841A1 (en) | 2007-01-04 |
| JP5298334B2 (ja) | 2013-09-25 |
| MY145066A (en) | 2011-12-15 |
| TW200727893A (en) | 2007-08-01 |
| EP1893291A1 (en) | 2008-03-05 |
| KR101335942B1 (ko) | 2013-12-04 |
| TWI387452B (zh) | 2013-03-01 |
| EP1893291B1 (en) | 2010-03-03 |
| DE602006012670D1 (de) | 2010-04-15 |
| JP2008546778A (ja) | 2008-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054790A1 (es) | Metodos para el tratamiento de disfuncion sexual | |
| ECSP10010556A (es) | Piridinas y pirazinas como inhibidores de pi3k | |
| EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
| EA201001013A1 (ru) | Бис(сульфониламино)производные для применения в терапии | |
| MA34604B1 (fr) | Derives de la pyrazine en tant que bloqueurs de l'enac | |
| EA201001595A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| AR076360A1 (es) | Derivados de 3,3'-espiroindolinona y su uso en el tratamiento del cancer | |
| ECSP088871A (es) | Derivados de triazolopirazina | |
| CY1115262T1 (el) | Ανταγωνιστες trpv1 και χρησεις αυτων | |
| ECSP045073A (es) | Nuevos derivados de piperazina | |
| AR069789A1 (es) | Pirazoles condensados, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento del sida o el arc. | |
| MX2009011601A (es) | Agentes terapeuticos utiles para tratar el dolor. | |
| RU2012155118A (ru) | Способы лечения биполярного расстройства | |
| SG148178A1 (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
| UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
| AR036248A1 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| CY1109763T1 (el) | Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης | |
| RU2016118399A (ru) | Производные 4-аминометилбензойной кислоты | |
| PE20090307A1 (es) | Derivados de 7-alquinil-1,8-naftiridonas como agentes inhibidores de vegfr-3 | |
| PE20141940A1 (es) | Compuestos triciclicos, composiciones que los comprenden y usos de los mismos | |
| EA201171339A1 (ru) | Способ снижения внутриглазного давления у людей | |
| EA200970705A1 (ru) | Новые фармацевтические композиции | |
| EA201070010A1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |